Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × Ramucirumab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Neoplasm Metastasis 2 Lung Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Metastatic Gastric Adenocarcinoma 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Advanced Gastric or EGJ Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 11 Rituximab 9 Specimen Handling 8 fludarabine 7 obinutuzumab 6 ibrutinib 6 Magnetic Resonance Spectroscopy 6 Biopsy 5 tazemetostat 4 palbociclib 4 glofitamab 4 fludarabine phosphate 4 X-Rays 4 Prednisone 4 Phantoms, Imaging 4 Lenalidomide 4 Doxorubicin 4 venetoclax 3 pirtobrutinib 3 olaparib 3 Vemurafenib 3 Nuclear Medicine Department, Hospital 3 Nivolumab 3 Immunotherapy, Adoptive 3 Gemcitabine 3 ulixertinib 2 tucatinib 2 tocilizumab 2 temsirolimus 2 polatuzumab vedotin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡